Acadia Healthcare Co. (NASDAQ:ACHC) shares fell 5.4% during mid-day trading on Thursday . The stock traded as low as $50.91 and last traded at $53.40, with a volume of 2,912,317 shares traded. The stock had previously closed at $56.43.

Several brokerages have issued reports on ACHC. Zacks Investment Research cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday. Jefferies Group reissued a “buy” rating and issued a $85.00 target price on shares of Acadia Healthcare in a research report on Monday, June 27th. Robert W. Baird reissued an “outperform” rating and issued a $69.00 target price on shares of Acadia Healthcare in a research report on Tuesday, June 14th. Leerink Swann reissued a “buy” rating on shares of Acadia Healthcare in a research report on Monday, May 2nd. Finally, Cantor Fitzgerald reissued a “buy” rating on shares of Acadia Healthcare in a research report on Friday, April 29th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $80.17.

The stock’s 50 day moving average is $57.76 and its 200 day moving average is $57.74. The firm has a market cap of $4.62 billion and a P/E ratio of 31.45.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Thursday, April 28th. The company reported $0.55 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.54 by $0.01. The business had revenue of $616.80 million for the quarter, compared to analyst estimates of $612.77 million. The company’s quarterly revenue was up 68.6% on a year-over-year basis. During the same period in the prior year, the company earned $0.43 earnings per share. On average, analysts forecast that Acadia Healthcare Co. will post $2.84 earnings per share for the current fiscal year.

A number of hedge funds and institutional investors have made changes to their positions in the stock. Wells Fargo & Company MN raised its position in shares of Acadia Healthcare by 51.3% in the fourth quarter. Wells Fargo & Company MN now owns 4,329,117 shares of the company’s stock valued at $270,397,000 after buying an additional 1,468,501 shares in the last quarter. Jennison Associates LLC raised its position in shares of Acadia Healthcare by 40.1% in the fourth quarter. Jennison Associates LLC now owns 1,280,675 shares of the company’s stock valued at $79,991,000 after buying an additional 366,545 shares in the last quarter. Monarch Partners Asset Management LLC raised its position in shares of Acadia Healthcare by 76.1% in the fourth quarter. Monarch Partners Asset Management LLC now owns 355,284 shares of the company’s stock valued at $22,191,000 after buying an additional 153,535 shares in the last quarter. Bank of Montreal Can raised its position in shares of Acadia Healthcare by 17.6% in the fourth quarter. Bank of Montreal Can now owns 349,672 shares of the company’s stock valued at $21,841,000 after buying an additional 52,353 shares in the last quarter. Finally, Century Capital Management LLC raised its position in shares of Acadia Healthcare by 1.4% in the fourth quarter. Century Capital Management LLC now owns 300,988 shares of the company’s stock valued at $18,800,000 after buying an additional 4,293 shares in the last quarter.

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.